semaglutide vs glipizide 12-month neurological and psychiatric outcomes of use for type 2 diabetes: a propensity-score matched cohort study Glucoregulatory Hormones | GLP-1/GIP Receptor

Lawsuits claim Ozempic, Wegovy, and other GLP-1 drugs cause serious side effects like gastroparesis

This study showcases the potential of pathway engineering to unlock novel C40 carotenoid variants for diverse industrial applications.

In ASCVD, semaglutide has demonstrated significant reductions in major adverse cardiovascular events, supported by findings from meta-analyses of trials in patients with T2DM and the SELECT trial for patients without T2DM

If pancreatitis is confirmed, GLP-1 receptor agonists should not be restartedthis is an absolute contraindication based on FDA labeling and major guideline ...

A protocol breach led to omission of preoperative gastric ultrasound

Conclusion This trial supports dosing oral semaglutide in accordance with prescribing information, which requires dosing in the fasting state